GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)
Status:
Active, not recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This study will assess whether the presence of a particular form of a gene, GABRA2, affects
the functional responses of the human brain to alcohol administration and will evaluate that
relationship in the context of factors known to increase the risk for future alcoholism.
Phase:
N/A
Details
Lead Sponsor:
Indiana University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)